GSK (GSK) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good ...

A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

As of 24 January at 11:34:44 am GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.